Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | LAP3 | P28838 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | METAP1 | P53582 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7716778 | 0.89 | CYP2D6 (0.39) | CYP2D6CYP2C9CYP2C19HSD17B10LAP3 | |
| SCHEMBL6132143 | 0.78 | CYP2D6 (0.41) | CYP2D6CYP2C9CYP2C19HSD17B10LAP3 | |
| SCHEMBL7715964 | 0.78 | CYP2D6 (0.41) | CYP2D6CYP2C9CYP2C19HSD17B10LAP3 | |
| SCHEMBL11318860 | 0.75 | MEN1 (0.34) | CYP2D6HSD17B10ALDH1A1ALOX15TDP1 | |
| SCHEMBL7714685 | 0.75 | METAP1 (0.42) | CYP2D6CYP2C9CYP2C19LAP3ALDH1A1 | |
| SCHEMBL17617126 | 0.73 | ALDH1A1 (0.42) | CYP2C19HSD17B10ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL17617134 | 0.73 | ALDH1A1 (0.42) | CYP2C19HSD17B10ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL17617122 | 0.73 | ALDH1A1 (0.42) | CYP2C19HSD17B10ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL235849 | 0.72 | ALDH1A1 (0.50) | HSD17B10ALDH1A1ALOX15TSHRLMNA | |
| SCHEMBL19557119 | 0.72 | ALDH1A1 (0.37) | CYP2C19HSD17B10ALDH1A1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6376512-B1 | FOR TREATING PHYSIOLOGICAL CONDITION IN PATIENT WHEREIN SAID CONDITION IS ASSOCIATED WITH A PHYSIOLOGICALLY DETRIMENTAL LEVELS OF INSULIN, GLUCOSE, FREE FATTY ACIDS, OR TRIGLYCERIDES | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-04-23 | — | — | US | disclosed |
| EP-0315399-B1 | Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same | RHONE POULENC RORER INT (US) | 1996-01-10 | — | — | EP | disclosed |
| US-5059610-A | QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-22 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |